Escherichia coli O157 interactions with human intestinal Caco-2 cells and the influence of fosfomycin.

No abstract is available for this paper.

• Publication year

  1998

• Venue

  Journal of Antimicrobial Chemotherapy

• Publication date

  1998-09-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1093/JAC/42.3.341PMID 9786474
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Effect of subinhibitory concentrations of antibiotics on extracellular shiga-like toxin I

  2005cited by this paper
• Neutrophil activation in the haemolytic uraemic syndrome: free and complexed elastase in plasma

  2004cited by this paper
• [Evaluation of antibiotics used for enterohemorrhagic Escherichia coli O157 enteritis--effect of various antibiotics on extracellular release of verotoxin].

  1997cited by this paper
• The effects of various antibacterial agents on the release of verotoxin against Escherichia coli O-157: H7 strains

  1997cited by this paper
• Modulatory effect of antibiotics on cytokine production by human monocytes in vitro

  1996cited by this paper
• Translocation of Shiga toxin across polarized intestinal cells in tissue culture

  1996cited by this paper
• Differentiation-associated toxin receptor modulation, cytokine production, and sensitivity to Shiga-like toxins in human monocytes and monocytic cell lines

  1996cited by this paper
• Plasma cytokine levels in hemolytic uremic syndrome.

  1995cited by this paper
• Tumor necrosis factor alpha induces endothelial galactosyl transferase activity and verocytotoxin receptors. Role of specific tumor necrosis factor receptors and protein kinase C.

  1995cited by this paper
• Cytokines in childhood hemolytic uremic syndrome and thrombotic thrombocytopenic purpura

  1995cited by this paper
• Tumor necrosis factor concentrations in hemolytic uremic syndrome patients and children with bloody diarrhea in Argentina.

  1995cited by this paper
• Bacterial Pathogenesis: A Molecular Approach

  1994cited by this paper
• Purified Shiga-like toxins induce expression of proinflammatory cytokines from murine peritoneal macrophages

  1994cited by this paper
• Haemolytic-uraemic syndrome in childhood: surveillance and case-control studies in Italy

  1994cited by this paper
• Hemolytic uremic syndrome: current pathophysiology and management.

  1994cited by this paper
• Some structures and processes of human epithelial cells involved in uptake of enterohemorrhagic Escherichia coli O157:H7 strains

  1994cited by this paper
• A continuing assessment of risk factors for the development of Escherichia coli O157:H7-associated hemolytic uremic syndrome.

  1994cited by this paper
• A Prospective Study of Shiga‐Like Toxin‐Associated Diarrhea in a Pediatric Population

  1994cited by this paper
• Interleukin-8 and polymorphoneutrophil leucocyte activation in hemolytic uremic syndrome of childhood.

  1992cited by this paper
• Shiga toxin-associated hemolytic uremic syndrome: combined cytotoxic effects of shiga toxin and lipopolysaccharide (endotoxin) on human vascular endothelial cells in vitro

  1992cited by this paper
• Tumor necrosis factor and interleukin-1 induce expression of the verocytotoxin receptor globotriaosylceramide on human endothelial cells: implications for the pathogenesis of the hemolytic uremic syndrome.

  1992cited by this paper
• Shiga toxin-associated hemolytic-uremic syndrome: combined cytotoxic effects of Shiga toxin, interleukin-1 beta, and tumor necrosis factor alpha on human vascular endothelial cells in vitro

  1991cited by this paper
• Evaluation of the role of Shiga and Shiga-like toxins in mediating direct damage to human vascular endothelial cells.

  1991cited by this paper
• Salmonella interactions with polarized human intestinal Caco-2 epithelial cells.

  1990influential reference
• Neutrophil-mediated endothelial injury in haemolytic uraemic syndrome.

  1989cited by this paper
• Infection by verocytotoxin-producing Escherichia coli

  1989cited by this paper
• Basolateral secretion of kappa light chain in the polarised epithelial cell line, Caco-2.

  1989cited by this paper
• An increase in the antimicrobial activity in vitro of fosfomycin under anaerobic conditions.

  1989cited by this paper
• Pathogenesis of haemolytic uraemic syndrome.

  1988cited by this paper
• Pathogenesis of haemolytic uraemic syndrome.

  1987cited by this paper
• The association between idiopathic hemolytic uremic syndrome and infection by verotoxin-producing Escherichia coli.

  1985cited by this paper
• Epithelial properties of human colonic carcinoma cell line Caco-2: electrical parameters.

  1984cited by this paper
• A human colonic tumor cell line that maintains vectorial electrolyte transport.

  1984cited by this paper
• Escherichia coli cytotoxin, haemolytic-uraemic syndrome, and haemorrhagic colitis.

  1983cited by this paper
• National Committee for Clinical Laboratory Standards.

  1980cited by this paper
• [Therapeutic effect of fosfomycin on bacillary dysentery and related enterocolitic infections].

  1975cited by this paper
• of Nebraska - Lincoln DigitalCommons@University of Nebraska - Lincoln Shiga and Shiga-Like Toxins Shiga and Shiga-Like Toxins

  year unknowncited by this paper

• Characterisation of the E. coli and Salmonella qseC and qseE mutants reveals a metabolic rather than adrenergic receptor role

  2022cites this paper
• Studies on Epidemiology of Microorganisms Related to Human Health Disorders, and Their Control

  2021cites this paper
• Lactoferrin inhibits E. coli O157:H7 growth and attachment to intestinal epithelial cells

  2018cites this paper
• Glycomacropeptide Reduces Intestinal Epithelial Cell Barrier Dysfunction and Adhesion of Entero-Hemorrhagic and Entero-Pathogenic Escherichia coli in Vitro

  2017cites this paper
• Development of an in vitro co-culture model of the human small intestine in homeostatic or inflamed state and its application in nanotoxicological research

  2017cites this paper
• Sublethal injury and virulence changes in Listeria monocytogenes and Listeria innocua treated with antimicrobials carvacrol and citral.

  2015cites this paper
• A microfluidic cell culture device (μFCCD) to culture epithelial cells with physiological and morphological properties that mimic those of the human intestine

  2015cites this paper
• Interrelationship between Heliobacter pylori and P-glycoprotein: potential role in drug resistance and carcinogenicity

  2013cites this paper
• Versorgung und Behandlung von EHEC/HUS-Patienten

  2012cites this paper
• New strategies for prevention of E. coli O157:H7 infection in sheep

  2011cites this paper
• Mouse Models of Escherichia coli O157:H7 Infection and Shiga Toxin Injection

  2011cites this paper
• EHEC infection and antibiotic therapy

  2011cites this paper
• REVIEW: Small Bowel Review: Diseases of the Small Intestine

  2004cites this paper
• Catecholamines Modulate Escherichia coli O157:H7 Adherence to Murine Cecal Mucosa

  2003cites this paper
• Risk of hemolytic uremic syndrome after antibiotic treatment of Escherichia coli O157:H7 enteritis: a meta-analysis.

  2002cites this paper
• Adhesion of Lactic Acid Bacteria to Caco‐2 Cells and Their Effect on Cytokine Secretion

  2002cites this paper
• Effects of Azithromycin on Shiga Toxin Production by Escherichia coli and Subsequent Host Inflammatory Response

  2002cites this paper
• Potential for using antibiotics combined with a Shiga toxin-absorbing agent for treating 0157:H7 Escherichia coli infections

  2002cites this paper
• REVIEW: Small Bowel Review: Diseases of the Small Intestine

  2001cites this paper
• Inhibition of Shiga toxin-induced tumor necrosis factor-alpha production and gene expression in human monocytic cells by CV6209.

  2001cites this paper
• Protective effect of anisodamine against Shiga toxin-1: inhibition of cytokine production and increase in the survival of mice.

  2001cites this paper
• Anisodamine Inhibits Shiga Toxin Type 2-Mediated Tumor Necrosis Factor-α Production in Vitro and in Vivo 1

  2001cites this paper
• Bacterial infections of the small intestine and colon.

  2000cites this paper
• Shiga toxin-producing Escherichia coli

  2000cites this paper
• Bacterial gut infections.

  1999cites this paper